Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/10/2025 | Mkt Perform → Underperform | Raymond James | |
| 4/3/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 11/11/2024 | $18.00 | Overweight → Neutral | Piper Sandler |
| 2/24/2023 | $21.00 | Neutral | Janney |
| 8/10/2021 | $23.00 → $26.00 | Neutral → Overweight | Piper Sandler |
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $21.9 million, or $0.42 per diluted share, and operating income(1) of $26.8 million, or $0.52 per diluted share, for the three months ended June 30, 2025. For the six months ended June 30, 2025, net income was $16.1 million, or $0.31 per diluted share, and operating income was $33.6 million, or $0.65 per diluted share. Second Quarter Highlights(2) Second-quarter operating performance continues to demonstrate our continued progress toward premium rate levels appropriate for the challenging conditions in the medical profession
The Doctors Company, the nation's largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers' compensation insurance, announced today that on July 2, 2025, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") with respect to the pending acquisition of ProAssurance by The Doctors Company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2
ProAssurance Corporation (NYSE:PRA) today announced that stockholders have voted overwhelmingly to approve its proposed acquisition by The Doctors Company. More than 99% of shares voted (including abstentions) were in favor of the proposal to approve the acquisition agreement. The transaction remains subject to the receipt of regulatory approvals and other customary closing conditions and is expected to close in the first half of 2026. Required regulatory approvals include the expiration or early termination of the waiting period (and any extension thereof) applicable to the consummation of the merger under the Hart-Scott-Rodino Act as well as approvals by the insurance regulators in the
Raymond James downgraded ProAssurance from Mkt Perform to Underperform
Citizens JMP downgraded ProAssurance from Mkt Outperform to Mkt Perform
Piper Sandler downgraded ProAssurance from Overweight to Neutral and set a new price target of $18.00
10-Q - PROASSURANCE CORP (0001127703) (Filer)
8-K - PROASSURANCE CORP (0001127703) (Filer)
8-K - PROASSURANCE CORP (0001127703) (Filer)
4 - PROASSURANCE CORP (0001127703) (Issuer)
4 - PROASSURANCE CORP (0001127703) (Issuer)
4 - PROASSURANCE CORP (0001127703) (Issuer)
SC 13G/A - PROASSURANCE CORP (0001127703) (Subject)
SC 13G - PROASSURANCE CORP (0001127703) (Subject)
SC 13G - PROASSURANCE CORP (0001127703) (Subject)
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $21.9 million, or $0.42 per diluted share, and operating income(1) of $26.8 million, or $0.52 per diluted share, for the three months ended June 30, 2025. For the six months ended June 30, 2025, net income was $16.1 million, or $0.31 per diluted share, and operating income was $33.6 million, or $0.65 per diluted share. Second Quarter Highlights(2) Second-quarter operating performance continues to demonstrate our continued progress toward premium rate levels appropriate for the challenging conditions in the medical profession
PHILADELPHIA, June 10, 2025 /PRNewswire/ -- The Board of Trustees of abrdn Income Credit Strategies Fund (the "Fund"), has declared a cash distribution of $0.328125 per share of the Fund's 5.250% Series A Perpetual Preferred Shares (NYSE: ACP PRA) ("Series A Preferred Shares"). The distribution is payable on June 30, 2025, to holders of Series A Preferred Shares of record on June 20, 2025 (ex-dividend date June 20, 2025). The Series A Preferred Shares trade on the NYSE under the symbol "ACP PRA", are rated "A2" by Moody's Investors Service and have an annual dividend rate of $
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported a net loss of $5.8 million, or $0.11 per diluted share, and operating income(1) of $6.8 million, or $0.13 per diluted share, for the three months ended March 31, 2025. Highlights(2) First-quarter performance demonstrated continued progress in our efforts to achieve premium rate levels appropriate for the challenging conditions in the medical professional liability and workers' compensation markets; net results were impacted by non-operating items totaling $12.6 million. Details on those non-operating items can be found under the heading "Re
PICA Group, part of the ProAssurance family of companies, announced today the retirement of Dr. Ross E. Taubman, DPM. effective March 31, 2024, after 12 years of dedicated service. During his tenure, Dr. Taubman has been a valuable leader of the PICA Group team, overseeing PICA and OUM since he joined the company in 2011, as well as assuming responsibility as the head of PICA Group's additional business units, DentistCare and LawyerCare, in 2019. Throughout his time as President, Dr. Taubman demonstrated exceptional strategic vision and a passion for innovation. His commitment has helped PICA Group expand its market presence and deliver exceptional results. Under his guidance, PICA has
BIRMINGHAM, Ala.--(BUSINESS WIRE)--The Board of Directors of ProAssurance Corporation (NYSE:PRA) has declared a cash dividend of $0.05 per common share, payable on January 7, 2021 to shareholders who own our stock as of December 22, 2020. For 2020, our dividend policy anticipates a total annual dividend of $0.72 per share. On an annualized basis going forward, our policy anticipates annual dividends of $0.20 per share to be paid in equal quarterly installments. However, any decision to pay future cash dividends will be subject to the Board’s final determination after a comprehensive review of the company’s financial performance, future expectations, and other factors deemed relev